glyceraldehyde 3-phosphate dehydrogenase (304-313) has been researched along with tryptophan in 1 studies
| Studies (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Trials (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Recent Studies (post-2010) (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Studies (tryptophan) | Trials (tryptophan) | Recent Studies (post-2010) (tryptophan) |
|---|---|---|---|---|---|
| 99 | 1 | 18 | 32,762 | 936 | 7,183 |
| Protein | Taxonomy | glyceraldehyde 3-phosphate dehydrogenase (304-313) (IC50) | tryptophan (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 2.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antoniadi, G; Eleftheriadis, T; Liakopoulos, V; Pissas, G; Stefanidis, I; Tsogka, K | 1 |
1 other study(ies) available for glyceraldehyde 3-phosphate dehydrogenase (304-313) and tryptophan
| Article | Year |
|---|---|
Activation of general control nonderepressible 2 kinase protects human glomerular endothelial cells from harmful high-glucose-induced molecular pathways.
Topics: Blood Glucose; Cells, Cultured; Diabetic Nephropathies; Glucose Transporter Type 1; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Peptide Fragments; Protective Factors; Protein Kinase C; Tryptophan; Urothelium | 2016 |